18:59 , Nov 3, 2017 |  BC Week In Review  |  Financial News

BioArctic prices SSE IPO

On Oct. 12, neurodegenerative disease company BioArctic AB (SSE:BIOA B) raised SEK700 million ($83.6 million) through the sale of 29.2 million shares at SEK24 in an IPO on NASDAQ Stockholm underwritten by Carnegie Investment Bank...
20:30 , Jun 23, 2017 |  BC Week In Review  |  Financial News

BoneSupport raises SEK500M in IPO

On June 21, bioceramics company BoneSupport AB (SSE:BONEX) raised SEK500 million ($57.2 million) through the sale of 17.2 million shares at SEK29 in an IPO underwritten by Carnegie Investment Bank and ABG Sundal Collier. Swedbank...
20:23 , Jun 21, 2017 |  BC Extra  |  Financial News

BoneSupport rises after SEK500M IPO

Bioceramics company BoneSupport AB (SSE:BONEX) rose SEK3 (10%) to SEK32 in its first day of trading Wednesday after it raised SEK500 million ($57.2 million) through the sale of 17.2 million shares at SEK29 in an...
02:16 , Apr 22, 2017 |  BioCentury  |  Finance

Sweden heating up

Following a nearly 15-year deep freeze, Stockholm has become one of the hottest European markets for biotech IPOs. The recent boom reflects a ripening of several years of investment in the early stage life sciences...
23:53 , Feb 24, 2017 |  BC Extra  |  Financial News

Oncopeptides raises SEK650M in IPO

Oncopeptides AB (SSE:ONCO) gained SEK2.4 to SEK44.3 in its first day of trading after raising SEK650 million ($72.7 million) through the sale of 14.1 million shares at SEK46 in an IPO underwritten by ABG Sundal...
21:36 , Feb 24, 2017 |  BC Week In Review  |  Financial News

Oncopeptides completes IPO

On Feb. 22, cancer company Oncopeptides AB (SSE:ONCO) raised SEK650 million ($72.7 million) through the sale of 14.1 million shares at SEK46 in an IPO underwritten by ABG Sundal Collier, Carnegie Investment Bank and DNB...
07:00 , Jul 14, 2014 |  BC Week In Review  |  Financial News

Oasmia completes private placement

Oasmia Pharmaceutical AB (SSE:OASM A), Uppsala, Sweden   Business: Cancer, Drug delivery, Veterinary   Date completed: 2014-07-03   Type: Private placement   Raised: SEK50 million ($7.4 million)   Shares: 2.5 million   Price: SEK20  ...
07:00 , Mar 17, 2014 |  BC Week In Review  |  Financial News

Oasmia completes private placement

Oasmia Pharmaceutical AB (SSE:OASM A), Uppsala, Sweden   Business: Cancer, Drug delivery, Veterinary   Date completed: 3/7/14   Type: Private placement   Raised: SEK72.2 million ($11.3 million)   Shares: 3.8 million   Price: SEK19  ...
08:00 , Nov 17, 2008 |  BioCentury  |  Finance

Ebb & Flow

Two of the many micro-cap companies with a year or less of cash secured some breathing room last week. Cardiovascular and gastrointestinal company ARYx (NASDAQ:ARYX) raised $21.6 million in a private placement, while stem cell...